ArticleJHEP reports : innovation in hepatology2026
Efficacy and safety of immune checkpoint inhibitors in patients with high microsatellite instability/mismatch repair-deficient advanced cholangiocarcinoma: A propensity score-matched study.
Mingjian Piao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.